Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in Fatal COVID-19
Jasmin Sidhu(Imperial College London), Lynn Maslen(St Mary's Hospital), Felicity Liew(Imperial College London), Wilna Oosthuyzen(Roslin Institute), Christopher Davis(California University of Pennsylvania), Hayley Hardwick(University of Liverpool), Debby Bogaert(MRC Centre for Regenerative Medicine), Marc‐Emmanuel Dumas(Centre National de la Recherche Scientifique), Tom Fletcher, Annemarie B Docherty(Edinburgh Royal Infirmary), Matthew K. Siggins(Lung Institute), Paul Klenerman(John Radcliffe Hospital), J. Kenneth Baillie(NHS Lothian), Kanta Chechi, William Barclay(Imperial Valley College), Gonçalo dos Santos Correia, Saye Khoo(University of Liverpool), Beatrice Alex(Imperial College London), Benjamin Bach(University of Edinburgh), Peter Horby, Antonia Ho(University of Glasgow), Thushan I. de Silva(Sheffield Teaching Hospitals NHS Foundation Trust), Ryan S. Thwaites(University of Oxford), Ana da Silva Filipe(MRC University of Glasgow Centre for Virus Research), Meera Chand(St Thomas' Hospital), Matthew R. Lewis(Hammersmith Hospital), Ashley Sanchez Sevilla Uruchurtu(Lung Institute), Jake Dunning(University of Oxford), Julian L. Griffin(University of Aberdeen), Rishi K Gupta, Samreen Ijaz(Environment Agency), Shona C. Moore(University of Liverpool), Lance Turtle(University of Liverpool), Petros Andrikopoulos(Università degli Studi di Enna Kore), G Cooke, Sonia Liggi(St Mary's Hospital), Karl Holden(St Mary's Hospital), Andrew Law, Chris Green(St Mary's Hospital), Emma C. Thomson(MRC University of Glasgow Centre for Virus Research), William Greenhalf, Wei Shen Lim(Nottingham University Hospitals NHS Trust)
Cited by 9
Related Papers
Proposed minimum reporting standards for chemical analysis
|Metabolomics|2007|5k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
An atlas of active enhancers across human cell types and tissues
|Nature|2014|2.8k